Biomarker study a game-changer for Parkinson’s disease

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 53%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

⭐ Research Highlight: A new study provides the strongest support yet for abnormal α-synuclein as a diagnostic biomarker for ParkinsonsDisease, showing up even before symptoms are evident in some people TheLancetNeuro

A hallmark of Parkinson’s disease is the presence of misfolded aggregates of α-synuclein in the brain.

A test to detect α-synuclein ‘seeds’ in cerebrospinal fluid — the seed amplification assay — has shown the potential for α-synuclein as a diagnostic biomarker, but robust validation in large and varied cohorts has been lacking.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 451. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Local events highlight National Crime Victims' Rights WeekThere have been a number of local activities for National Crime Victims’ Rights Week, but as the name implies: it’s a nationwide effort. It calls on all of us t
Source: cbsaustin - 🏆 595. / 51 Read more »